Markets:

Overview

News

Currencies

International

Treasuries

Nkarta, Inc. - Common Stock (NQ:NKTX)

1.970 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Nkarta, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

34 Stocks Moving In Tuesday's Mid-Day Session ↗

April 26, 2022

Gainers Avadel Pharmaceuticals plc. (NASDAQ: AVDL) shares gained 36.3% to $5.74. Shares closed down 36% on Monday, seemingly on no news. Avadel issued a press release Tuesday...

Via Benzinga

Futures Slide Ahead Of Tech Earnings Deluge ↗

April 26, 2022

Markets in general are preoccupied by the prospect of tighter monetary policy conditions from global central banks to stem rising prices.

Via Talk Markets

Expert Ratings for Nkarta ↗

April 26, 2022

Analysts have provided the following ratings for Nkarta (NASDAQ:NKTX) within the last quarter:

Via Benzinga

The Daily Biotech Pulse: Protagonist's Ulcerative Colitis Study Disappoints, Gilead's Remdesivir Approved For Pediatric COVID-19 Patients, FDA Gives Nod To Gamida's Cell Therapy Trial, Fast Track Tag For Vascular Biogenics Ovarian Cancer Gene Therapy ↗

April 26, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Investors Cheer Nkarta's First NK Cell Data With Multiple Complete Responses ↗

April 25, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 26, 2022

Via Benzinga

10 Biggest Price Target Changes For Tuesday ↗

April 26, 2022

HC Wainwright & Co. raised Nkarta, Inc. (NASDAQ: NKTX) price target from $25 to $36. Nkarta shares fell 7.2% to $17.38 in pre-market trading.

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Rises 70 Points; Eliem Therapeutics Shares Slide ↗

April 25, 2022

U.S. stocks pared losses toward the end of trading, with the Nasdaq Composite gaining around 70 points on Monday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 25, 2022

Via Benzinga

60 Biggest Movers From Yesterday ↗

April 26, 2022

Gainers Nkarta, Inc. (NASDAQ: NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two...

Via Benzinga

Mid-Day Market Update: Crude Oil Tumbles Over 6%; Nkarta Shares Spike Higher ↗

April 25, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 400 points on Monday.

Via Benzinga

34 Stocks Moving In Monday's Mid-Day Session ↗

April 25, 2022

Gainers Nkarta, Inc. (NASDAQ: NKTX) shares jumped 108.6% to $16.21 after the company announced Phase 1 data from independent dose finding studies of its two lead chimeric antigen...

Via Benzinga

Why Is Nkarta (NKTX) Stock Soaring 90% Today? ↗

April 25, 2022

Nkarta (NKTX) stock is rocketing higher on Monday after the company released preliminary data from a Phase 1 clinical trial.

Via InvestorPlace

Mid-Morning Market Update: Markets Open Lower; Dow Tumbles Over 300 Points ↗

April 25, 2022

U.S. stocks opened lower this morning, with the Dow Jones dropping more than 300 points on Monday.

Via Benzinga

Benzinga's Daily Brief On Trending Tickers For April 25, 2022: Twitter, Coca-Cola, Nkarta, And More ↗

April 25, 2022

Benzinga’s “Daily Brief On Trending Tickers” features top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items...

Via Benzinga

How Nkarta Stock Scored A 90% Surge On Its 'Natural Killers' In Cancer ↗

April 25, 2022

The biotech reported promising results for cell therapies without extreme side effects.

Via Investor's Business Daily

Why Nkarta Stock Is Soaring Today ↗

April 25, 2022

Nkarta Inc (NASDAQ: NKTX) shares are trading higher Monday morning after the company announced positive preliminary Phase 1 data from independent dose finding studies. The...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 25, 2022

Via Benzinga

The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More ↗

April 24, 2022

Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

April 20, 2022

On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...

Via Benzinga

43 Stocks Moving In Tuesday's Mid-Day Session ↗

March 22, 2022

Gainers Forge Global Holdings Inc. (NYSE: FRGE) shares jumped 67.7% to $16.95. True Global Ventures’ portfolio company Forge Global Holdings completed its business...

Via Benzinga

35 Biggest Movers From Friday ↗

October 11, 2021

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares surged 96% to close at $38.41 on Friday. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for...

Via Benzinga

61 Biggest Movers From Yesterday ↗

December 02, 2021

Gainers Arbutus Biopharma Corporation (NASDAQ: ABUS) shares jumped 44.1% to close $4.61 on above-average volume on Wednesday. The Patent Trial and Appeals Board has turned down...

Via Benzinga

Topics Intellectual Property

28 Stocks Moving In Friday's Mid-Day Session ↗

October 08, 2021

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares climbed 60.8% to $31.51. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for anti-neutrophil...

Via Benzinga

Nkarta Expects Initial Data From CAR NK Cell Therapy In Blood Cancer In 2022 ↗

October 08, 2021

Nkarta Inc (NASDAQ: NKTX) has updated guidance on initial data readout of Phase 1 trial of NKX101 in relapsed or refractory acute myeloid leukemia or higher-risk...

Via Benzinga

53 Biggest Movers From Friday ↗

September 07, 2021

Gainers Innate Pharma S.A. (NASDAQ: IPHA) shares surged 47.1% to settle at $6.15 on Friday after SVB Leerink upgraded the stock from Market Perform to Outperform. Vera...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 15, 2021

Gainers Nkarta (NASDAQ:NKTX) shares moved upwards by 8.03% to $30.0 during Thursday's regular session. The current volume of 180.7K shares is 71.9% of Nkarta's...

Via Benzinga

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs ↗

October 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 16, 2021 ↗

July 16, 2021

Upgrades According to Citigroup, the prior rating for Alcoa Corp (NYSE:

Via Benzinga

Nkarta Unveils Plans For New San Francisco HQ, Manufacturing Site ↗

July 14, 2021

Nkarta Therapeutics Inc (NASDAQ: NKTX) will be moving into an 88,000-square-foot facility that will not only serve as its newest headquarters but will support the...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Nkarta, Inc. - Common Stock (NQ:NKTX)

Headline News about Nkarta, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today